These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31698924)

  • 1. Apparent diffusion coefficient (ADC) values of serous, endometrioid, and clear cell carcinoma of the ovary: pathological correlation.
    Ono T; Kishimoto K; Tajima S; Maeda I; Takagi M; Suzuki N; Mimura H
    Acta Radiol; 2020 Jul; 61(7):992-1000. PubMed ID: 31698924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial cancer: correlation of apparent diffusion coefficient (ADC) with tumor cellularity and tumor grade.
    Kishimoto K; Tajima S; Maeda I; Takagi M; Ueno T; Suzuki N; Nakajima Y
    Acta Radiol; 2016 Aug; 57(8):1021-8. PubMed ID: 26486600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
    Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma.
    Ma FH; Qiang JW; Zhang GF; Li HM; Cai SQ; Rao YM
    J Ovarian Res; 2016 Jul; 9(1):40. PubMed ID: 27377917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary.
    Morioka S; Kawaguchi R; Yamada Y; Iwai K; Yoshimoto C; Kobayashi H
    J Ovarian Res; 2019 Feb; 12(1):20. PubMed ID: 30803452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment maximum standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic factor for ovarian clear cell carcinoma and low-grade serous carcinoma.
    Matsuura T; Otsuka I; Ouchi T; Ouchi E; Asano R; Miyasaka N
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):305-310. PubMed ID: 33678332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
    Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
    Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer?
    Yan B; Zhao T; Liang X; Niu C; Ding C
    Acta Radiol; 2018 Mar; 59(3):363-370. PubMed ID: 28696169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma.
    Mori T; Kato H; Kawaguchi M; Hatano Y; Ishihara T; Noda Y; Hyodo F; Matsuo M; Furui T; Morishige KI
    Eur Radiol; 2022 Jun; 32(6):4128-4136. PubMed ID: 35061079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-tumor ADC histogram analysis for differentiating endometriosis-related tumors: seromucinous borderline tumor, clear cell carcinoma and endometrioid carcinoma.
    Lu J; Zhao S; Ma F; Li H; Li Y; Qiang J
    Abdom Radiol (NY); 2023 Feb; 48(2):724-732. PubMed ID: 36401131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.
    Lu L; Wang S; Zhu Q; Qu Y; Gu W; Ning Y; Chen X; Wang Y
    Pathol Res Pract; 2018 Aug; 214(8):1087-1094. PubMed ID: 29866423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogram Analysis of Apparent Diffusion Coefficient on Diffusion Weighted Magnetic Resonance Imaging in Differentiation between Low and High Grade Serous Ovarian Cancer.
    Liu X; Wang T; Wang Y; Wang J; Jin J; Zhang G; Zhang H
    Curr Med Imaging; 2023; 19(2):167-174. PubMed ID: 35585829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
    Vang R; Levine DA; Soslow RA; Zaloudek C; Shih IeM; Kurman RJ
    Int J Gynecol Pathol; 2016 Jan; 35(1):48-55. PubMed ID: 26166714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetic resonance imaging-based radiomics analysis of the differential diagnosis of ovarian clear cell carcinoma and endometrioid carcinoma: a retrospective study.
    Takeyama N; Sasaki Y; Ueda Y; Tashiro Y; Tanaka E; Nagai K; Morioka M; Ogawa T; Tate G; Hashimoto T; Ohgiya Y
    Jpn J Radiol; 2024 Jul; 42(7):731-743. PubMed ID: 38472624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent diffusion MRI-based microstructural mapping for differentiating high-grade serous ovarian cancer from serous borderline ovarian tumor.
    Cao Y; Lu Y; Shao W; Zhai W; Song J; Zhang A; Huang S; Zhao X; Cheng W; Wu F; Chen T
    Eur J Radiol; 2024 Sep; 178():111622. PubMed ID: 39018648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI of epithelial ovarian cancers: correlation of apparent diffusion coefficient values with histologic grade and surgical stage.
    Oh JW; Rha SE; Oh SN; Park MY; Byun JY; Lee A
    Eur J Radiol; 2015 Apr; 84(4):590-5. PubMed ID: 25623826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
    Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.
    Li M; Li H; Liu F; Bi R; Tu X; Chen L; Ye S; Cheng X
    J Ovarian Res; 2017 Feb; 10(1):9. PubMed ID: 28187748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian Carcinoma: A Single-Centre Eight-Year Case-Series Study with Survival Analysis.
    Subtirelu GD; Steriu A; Bratucu E
    Chirurgia (Bucur); 2024 Aug; 119(4):373-384. PubMed ID: 39250607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.